secwatch / observer
8-K filed June 2, 2023, 7:59 PM ET ticker TELA CIK 0001561921
other confidence high sentiment neutral materiality 0.15

TELA Bio stockholders elect Lisa Colleran and Doug Evans as Class I directors; ratify KPMG as auditor

TELA Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TELA Bio, Inc. shareholders approved Election of Class I Directors at the 2023-06-01 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-01
Exact text from the filing
Each of Lisa Colleran and Doug Evans were elected to the Board to serve as Class I directors until the 2026 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Lisa Colleran 14,316,642 1,055,675 1,821,457 Doug Evans 13,535,182 1,837,135 1,821,457
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

TELA Bio, Inc. shareholders approved Ratification of Independent Registered Public Accountants at the 2023-06-01 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-01
Exact text from the filing
The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified, as follows: Votes For Votes Against Abstentions Broker Non-Votes 17,188,505 3,312 1,957 –
View on SEC.gov

557 shareholder votes filed in the last 30 days. Browse all shareholder votes →

TELA Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-067533
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.